Skip to content


Emtriva (emtricitabine) is a small molecule pharmaceutical. Emtricitabine was first approved as Emtriva on 2003-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Emtriva's patent is valid until 2021-03-09 (FDA).
Trade Name Emtriva
Common Name Emtricitabine
Indication hiv infections
Drug Class Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives
Get full access now